Dichloroisoprenaline
![](/Images/godic/202501/08/Dichloroisoprenaline.svg4153.png")
-Dichlorosisoproterenol_Enantiomers_Structural_Formulae4153.png")
Dichloroisoprenaline (DCI), also known as dichloroisoproterenol, was the first beta blocker ever to be developed. It is non-selective for the β1-adrenergic and β2-adrenergic receptors. DCI has low potency and acts as a partial agonist/antagonist at these receptors.